The following article abstract is about the therapeutic uses and potential of 'Botulinum Neurotoxin' which is produced from the bacterium Clostridium botulinum.
The article gives an insight into the therapeutic potential of bacterial toxins.
PYC is not mentioned
SoT
........................................
Botulinum Neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.
Kostrzewa RM, Segura-Aguilar J.
Abstract:
Botulinum neurotoxin (BoNT), for more than a hundred years, has been a recognized poisonous principle in spoiled food. As it's chemical structure became unraveled, and as more knowledge was gained over it's mechanism of toxicity, it became clear that BoNT had the potential to act therapeutically as a targeted toxin that could inactivate specific nerve populations, and thus achieve a therapeutic goal. BoNT has evolved over the past 25 years into a viable therapeutic, now being a first line treatment for dystonia, overtly altering the course of progression of this disorder.
BoNT is used for hyperhidrosis and gustatory sweating syndrome, alleviation of pain, as a treatment for overactive bladder, achalasia and anal fissure; and it has gained popularity as a cosmetic aid. Many other possible uses are being explored. The greatest potential for BoNT may lie in its being a molecular Trojan Horse - able to carry a specific enzyme or specific drug to the inside of a cancer or other type of cell while bypassing other cells and thereby having little or no ill effect. BoNT's pharmaceutical potential is boundless.
.......................................
Here is the link
- Forums
- ASX - By Stock
- PYC
- Bacterial Toxins
PYC
pyc therapeutics limited
Add to My Watchlist
1.54%
!
$1.32

Bacterial Toxins
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.32 |
Change
0.020(1.54%) |
Mkt cap ! $769.9M |
Open | High | Low | Value | Volume |
$1.30 | $1.33 | $1.29 | $1.054M | 804.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 80628 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.32 | 53944 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 80628 | 1.300 |
2 | 1235 | 1.290 |
1 | 1567 | 1.285 |
3 | 29010 | 1.275 |
1 | 13987 | 1.265 |
Price($) | Vol. | No. |
---|---|---|
1.320 | 53944 | 2 |
1.330 | 10800 | 2 |
1.340 | 11200 | 1 |
1.345 | 45000 | 1 |
1.350 | 10000 | 1 |
Last trade - 16.10pm 03/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Matthew Kowal / Andy Burger, CCO / Head of E-Commerce
Matthew Kowal / Andy Burger
CCO / Head of E-Commerce
SPONSORED BY The Market Online